All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

axios-local

axios-pro

axios-live

the-axios-show

Sunrise Group raised $29 million and is eyeing profitability by the end of 2027, CEO Laurent Martinot tells Axios Pro exclusively. 

Why it matters: The Belgian sleep health startup may pursue acquisitions of durable medical equipment vendors early next year, he says. 

Catch up quick: The company acquired Dreem Health, a digital sleep clinic focused on sleep apnea, in 2024.

Follow the money: The unlabeled round was led by Eurazeo and joined by Amazon's Alexa Fund, WE International, Kurma Partners and Vives Fund. 

Sunrise closed the round in June and plans to raise again around June 2027.

How it works: Founded in 2015, Sunrise employs clinicians who specialize in sleep-related conditions. After an initial, virtual consultation, eligible patients complete a sleep test at home using medical devices the company sends them. 

Following the test, patients meet with a Sunrise provider to go over results and devise a care plan.

It sells its offering directly to consumers, leveraging health providers and medical device manufacturers as a marketing channel.

Zoom in: The company will use the proceeds of this round to scale in the US.

"It's not 2021 anymore, so we want to make sure we have a plan that leads to profitability," Martinot says.

State of play: A number of sleep-focused startups have raised money this year, in a bid to tap into the 30 million-patient market in the U.S.

Eight Sleep, a New York-based developer of smart sleep products, raised $100 million in Series D funding last month.

Mosanna Therapeutics launched in June with $80 million in funding to for its nasal spray that aims to help patients with obstructive sleep apnea.

The same month, EnsoData, a Madison, Wisconsin-based company, raised $20 million to accelerate its AI-powered sleep medicine tools.

Khosla Ventures backed Somnee, a Berkeley, California-based sleep aid device company, in a $10 million seed extension round, also announced in June.

Exclusive: Sunrise Group raises $29M for at-home sleep test

The Belgian sleep health startup may pursue acquisitions of durable medical equipment vendors early next year.

Illustration of a pillow in the shape of a hundred dollar bill on a bedspread

Sunrise Group raised $29 million and is eyeing profitability by the end of 2027, CEO Laurent Martinot tells Axios Pro exclusively. Why it matters: The Belgian sleep health startup may pursue acquisitions of durable medical equipment vendors early next year, he says.

Exclusive: Sunrise Group raises $29M for at-home sleep test

What to read next